Hancom MDS Inc (086960) — Cash Flow Reinvestment Rate
Hancom MDS Inc (086960) has a Cash Flow Reinvestment Rate of 0.31x as of June 2025, reinvesting ₩2.70 Billion (capex ₩900.67 Million plus investments ₩1.80 Billion) from operating cash flow of ₩8.59 Billion. Explore reinvestment intensity of Hancom MDS Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hancom MDS Inc Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Hancom MDS Inc across 13 annual periods. Also explore Hancom MDS Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hancom MDS Inc (2007–2024)
Year-by-year capital reinvestment analysis for Hancom MDS Inc. For live market cap and broader valuation context, see 086960 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.54x | ₩7.36 Billion | ₩2.90 Billion | ₩1.42 Billion | ▲ +1920.4% |
| 2023 | 0.13x | ₩3.31 Billion | ₩26.32 Billion | ₩798.10 Million | ▼ -91.2% |
| 2021 | 1.42x | ₩4.03 Billion | ₩2.83 Billion | ₩1.27 Billion | ▼ -9.9% |
| 2020 | 1.58x | ₩10.70 Billion | ₩6.78 Billion | ₩2.48 Billion | ▼ -5.0% |
| 2019 | 1.66x | ₩8.22 Billion | ₩4.95 Billion | ₩2.20 Billion | ▲ +87.3% |
| 2018 | 0.89x | ₩18.17 Billion | ₩20.47 Billion | ₩3.69 Billion | ▼ -28.2% |
| 2017 | 1.24x | ₩4.42 Billion | ₩3.57 Billion | ₩1.17 Billion | ▼ -0.5% |
| 2015 | 1.24x | ₩7.79 Billion | ₩6.27 Billion | ₩4.50 Billion | ▲ +226.1% |
| 2014 | 0.38x | ₩4.85 Billion | ₩12.73 Billion | ₩1.85 Billion | ▲ +43.4% |
| 2013 | 0.27x | ₩3.20 Billion | ₩12.06 Billion | ₩3.20 Billion | ▼ -71.4% |
| 2012 | 0.93x | ₩6.17 Billion | ₩6.63 Billion | ₩6.17 Billion | ▲ +563.2% |
| 2011 | 0.14x | ₩667.39 Million | ₩4.76 Billion | ₩667.39 Million | ▲ +4.5% |
| 2007 | 0.13x | ₩946.15 Million | ₩7.05 Billion | ₩946.15 Million | — |